menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Startup News

>

Hyderabad-...
source image

ISN

3w

read

30

img
dot

Image Credit: ISN

Hyderabad-based biotech startup Utopia Therapeutics raises $1.5 million

  • Hyderabad-based biotech startup Utopia Therapeutics has raised $1.5 million in seed funding from Whale Tank.
  • Utopia Therapeutics focuses on developing next-generation vaccines for chronic metabolic diseases like obesity.
  • The startup plans to use the funding to advance the preclinical development of its lead candidate, UT009, targeting obesity.
  • UT009 is an immunotherapeutic vaccine designed to reduce fat accumulation and improve metabolic health.
  • The investment will support UT009's progress towards regulatory toxicology studies, IND-enabling milestones, and Phase I clinical trials.
  • Utopia Therapeutics founders, Dr. Uday Saxena and Dr. Gopi Kadiyala, aim to redefine obesity treatment with UT009.
  • The startup's innovative approach differentiates UT009 from current obesity drugs by addressing the root causes of weight gain.
  • Dr. Jitendra Kumar, MD of BIRAC, praised the scientific and entrepreneurial growth demonstrated by companies like Utopia Therapeutics in India.
  • Whale Tank's Managing Partner, Dr. Markandeya Gorantla, emphasized Utopia's potential to disrupt the obesity market with its scientifically rigorous approach.
  • Utopia Therapeutics' funding history includes support from BIRAC, reflecting the encouraging ecosystem for deep-tech science in India.
  • The startup aims to bring Immunotherapeutics to the forefront of chronic disease management.
  • The investment will facilitate Utopia's journey towards clinical translation and potential global impact in addressing metabolic disorders.
  • Whale Tank's investment in Utopia signifies confidence in the startup's bold and innovative mission.
  • Utopia Therapeutics' founders are thrilled to have Whale Tank as a strategic partner in their quest to reinvent obesity treatment.
  • The seed funding enables Utopia Therapeutics to accelerate the development of UT009 and progress towards clinical trials.
  • The startup's work represents a significant step towards addressing the global obesity epidemic with new scientific approaches.

Read Full Article

like

1 Like

For uninterrupted reading, download the app